相关实验视频

Updated: Sep 16, 2025

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening

Published on: November 20, 2018

在阿尔茨海默氏病的长度聚,缩和认知衰退

Ellen Hanna Singleton¹, Niklas Mattsson-Carlgren^1,2,3, Alexa Pichet Binette¹

¹Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.

Alzheimer's & dementia : the journal of the Alzheimer's Association

|July 9, 2025

概括

基线定子发射断层扫描 (PET) 是阿尔茨海默病 (AD) 认知衰退的强有力的预测因素. 虽然纵向的-PET和MRI具有边际影响,但基线病理对于AD预后和治疗策略至关重要.

科学领域:

神经成像是一种神经成像.
阿尔茨海默氏症疾病研究研究
认知神经学认知神经学

背景情况:

在预测认知衰退方面,基线和纵向定子发射断层扫描 (PET) 和磁共振成像 (MRI) 的不同作用尚未完全理解.
粉样蛋白阳性个体是研究阿尔茨海默病 (AD) 进展的关键人群.

研究的目的:

调查基线和纵向-PET和MRI对粉样蛋白阳性个体认知衰退的独立贡献.
确定基线tau病理与持续的tau积累和结构变化的相对重要性,从而导致认知障碍.

主要方法:

来自瑞典BioFINDER-2研究的761名粉样蛋白阳性个体的分析.
使用了基线和纵向[18F]RO948-tau-PET和3-特斯拉结构MRI数据.
采用线性混合效应模型和线性回归,对相关共变量进行调整.

主要成果:

基线tau-PET与MRI相比,与认知衰退的相关性更强,特别是在新皮层区域.
基线tau-PET解释了认知能力下降的很大一部分 (54.0%-94.0%).
纵向的tau-PET和MRI显示了适度的调解效应 (2.0%-15.0%),模拟的tau-PET减少对认知轨迹的影响有限.

结论:

基线tau-PET是阿尔茨海默病纵向认知衰退的关键决定因素.
这些发现强调了初始tau总负担的预测意义.
结果表明,针对现有的病理可能比仅仅专注于减缓未来积累的认知结果更具影响力.

关键词:

阿尔茨海默病的疾病阿尔茨海默病的疾病.这就是为什么MRI是MRI.临床试验是指临床试验中的临床试验.认知认知认知在纵向的长度上.tau-PET的使用情况.

更多相关视频

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on ¹⁸F-AV-1451

Published on: April 18, 2025

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Longitudinal Studies

Longitudinal Studies

Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...